Medwave lands Primo double deal:
This article was originally published in Clinica
Medwave, the Danvers, Massachusetts-based developer of blood pressure monitors, has added its new Primo product to its existing supply agreements with US group purchasing organisations Amerinet and Novation. The device, which received FDA clearance in February, is a handheld, sensor-based spot blood pressure monitor that is placed on the wrist. It gives the patient's blood pressure reading and pulse rate in seconds and does not require any calibration, claims Medwave. Primo has also been approved for sale in Europe and Asia.